These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7598211)

  • 1. [Cardiovascular protection by estrogens: a calcium antagonist effect?].
    Sánchez García P
    An R Acad Nac Med (Madr); 1994; 111(4):779-82. PubMed ID: 7598211
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular protection by oestrogen--a calcium antagonist effect?
    Collins P; Rosano GM; Jiang C; Lindsay D; Sarrel PM; Poole-Wilson PA
    Lancet; 1993 May; 341(8855):1264-5. PubMed ID: 8098404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diltiazem: a new calcium antagonist in the Netherlands].
    Robbens EJ; Hagemeijer F
    Ned Tijdschr Geneeskd; 1986 Mar; 130(12):535-7. PubMed ID: 3960166
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent.
    Dhein S; Salameh A
    Circulation; 1999 Aug; 100(9):1011. PubMed ID: 10468534
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of some calcium antagonists in an experimental model of cardio-cerebral relationships].
    Di Giugno G; Mattioli GL; Rosa G; Ferrante L; Alampi D; Caruso R; Cantore GP
    Minerva Anestesiol; 1993 Oct; 59(10 Suppl 3):47-57. PubMed ID: 8290108
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of tetramethylpyrazine on the cardiovascular system].
    Wang ZL
    Sheng Li Ke Xue Jin Zhan; 1992 Oct; 23(4):313-7. PubMed ID: 1338806
    [No Abstract]   [Full Text] [Related]  

  • 8. CV response to calcium-entry blocking drugs.
    Millard RW; Schwartz A
    Circulation; 1982 Oct; 66(4):902. PubMed ID: 7116608
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cardiovascular effects of calcium antagonists drug (author's transl)].
    Thuillez C; Giudicelli JF
    Therapie; 1981; 36(2):107-21. PubMed ID: 7027518
    [No Abstract]   [Full Text] [Related]  

  • 10. The cardiovascular pharmacology of lidoflazine.
    Schaper W; Jageneau A; Xhonneux R
    Brux Med; 1970 Sep; 50(9):635-8. PubMed ID: 5510364
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative characteristics of the effect of various Ca2+ antagonists on coronary vessels and the myocardium].
    Tkachenko BI; Kostko SZ; Stepanova TG; Shil'krut BL
    Fiziol Zh (1978); 1986; 32(1):14-24. PubMed ID: 3956777
    [No Abstract]   [Full Text] [Related]  

  • 12. Oestrogen directly inhibits the cardiovascular L-type Ca2+ channel Cav1.2.
    Ullrich ND; Koschak A; MacLeod KT
    Biochem Biophys Res Commun; 2007 Sep; 361(2):522-7. PubMed ID: 17662243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacidipine decreases the honeybee venom-induced vasoconstriction of the isolated porcine coronary artery.
    Cerne K; Drevensek G; Budihna MV
    Pflugers Arch; 2000; 440(5 Suppl):R139-40. PubMed ID: 11005644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular system drugs. 2/12. Calcium inhibitors].
    Fein E; Limat S
    Soins; 2004 Apr; (684 Pt 1):61-2. PubMed ID: 15151081
    [No Abstract]   [Full Text] [Related]  

  • 15. Augmentation of coronary collaterals and protection against the consequences of coronary ligation following the administration of dipyridamole.
    Schmier J; Kaden F; Schmidt HD
    Brux Med; 1970 Sep; 50(9):617-22. PubMed ID: 5510362
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 1st communication: comparative studies on the cardiovascular effects of methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2,3- b]pyridine-5-carboxylate and its two enantiomers in experimental animals.
    Ueda M; Matsumura S; Masui M; Matsuura E; Uno O; Kawakami M; Ninomiya M; Adachi I
    Arzneimittelforschung; 1993 Dec; 43(12):1270-5. PubMed ID: 8141813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vascular protection with estrogen. In-vitro and in-vivo effects--mechanisms and clinical implication].
    Barton M; Wright E; Dai-Do D; Yang Z; Espinosa E; Arnet U; Lüscher TF
    Praxis (Bern 1994); 1997 Jan; 86(5):129-37. PubMed ID: 9064730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockers--is vasoselectivity relevant?
    Kayser SR
    Prog Cardiovasc Nurs; 1995; 10(1):35-9. PubMed ID: 7770440
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of SB 206284A, a novel neuronal calcium-channel antagonist, in models of cerebral ischemia.
    Wood NI; Barone FC; Benham CD; Brown TH; Campbell CA; Cooper DG; Evans ML; Feuerstein GZ; Hamilton TC; Harries MH; King PD; Meakin JE; Murkitt KL; Patel SR; Price WJ; Roberts JC; Rothaul AL; Samson NA; Smith SJ; Hunter AJ
    J Cereb Blood Flow Metab; 1997 Apr; 17(4):421-9. PubMed ID: 9143224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A symposium: nicardipine--a vasoselective calcium antagonist. September 13,1986, Washington, D.C.
    Am J Cardiol; 1987 Jun; 59(17):1J-37J. PubMed ID: 3604920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.